Mayo Clinic: Migraine Disorders trials

The registry lists 14 Migraine Disorders studies with Mayo Clinic as lead sponsor. 4 are open to participants now and 4 have results posted.

Phase 1 2Phase 2 1Phase 3 1Phase 4 4No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison StudyRecruitingNCT06972056Phase 4
• Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive MedicationsRecruitingNCT06401642Phase 4
• Sequential, Multiple Assignment, Double Randomized Preference, Migraine Behavioral TrialNot yet recruitingNCT06170281Not applicable
• Determining the Utility of a Behavioral Intervention in Chronic MigraineRecruitingNCT05415020Not applicable
• Imaging the Migraine Brain Pre- and Post-ErenumabCompletedNCT03773562Phase 4Results posted
• The MOTS (Medication Overuse Treatment Strategy) TrialCompletedNCT02764320Not applicableResults posted
• Metformin for the Prevention of Episodic Migraine (MPEM)CompletedNCT02593097Phase 3Results posted
• Greater Occipital Nerve Block for Migraine ProphylaxisCompletedNCT00915473Phase 4Results posted
• Treatments of Migraine with Triptans in Individuals with Elevated Cardiovascular Risk and in Pregnant WomenCompletedNCT05854992
• A Study of Wearable Devices to Predict MigrainesActive, not recruitingNCT05755945Not applicable
• A Study to Evaluate White Matter Hyperintensities in MigraineActive, not recruitingNCT05112289Not applicable
• Study of Intravenous Erenumab in Patients With Status MigrainosusWithdrawnNCT04920331Phase 1
• Safety and Efficacy of Fremanezumab for Migraine in Adult CADASILWithdrawnNCT04334408Phase 2
• Verapamil vs. Sertraline for Vestibular Migraine & Chronic Subjective DizzinessCompletedNCT01669304Phase 1